Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP294078.RAVa1Bt8cTfrfFn7I3KTfqL-XZGr7pGiNZNAcN_VX92fg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP294078.RAVa1Bt8cTfrfFn7I3KTfqL-XZGr7pGiNZNAcN_VX92fg130_assertion type Assertion NP294078.RAVa1Bt8cTfrfFn7I3KTfqL-XZGr7pGiNZNAcN_VX92fg130_head.
- NP294078.RAVa1Bt8cTfrfFn7I3KTfqL-XZGr7pGiNZNAcN_VX92fg130_assertion description "[We studied the responses of bcl-2 and bcl-X(L) genes in pharmacologic (acute incubation with methylpyridinium (MPP+)) and mitochondrial transgenic (cybrid) models of Parkinson disease C-I defects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294078.RAVa1Bt8cTfrfFn7I3KTfqL-XZGr7pGiNZNAcN_VX92fg130_provenance.
- NP294078.RAVa1Bt8cTfrfFn7I3KTfqL-XZGr7pGiNZNAcN_VX92fg130_assertion evidence source_evidence_literature NP294078.RAVa1Bt8cTfrfFn7I3KTfqL-XZGr7pGiNZNAcN_VX92fg130_provenance.
- NP294078.RAVa1Bt8cTfrfFn7I3KTfqL-XZGr7pGiNZNAcN_VX92fg130_assertion SIO_000772 10972966 NP294078.RAVa1Bt8cTfrfFn7I3KTfqL-XZGr7pGiNZNAcN_VX92fg130_provenance.
- NP294078.RAVa1Bt8cTfrfFn7I3KTfqL-XZGr7pGiNZNAcN_VX92fg130_assertion wasDerivedFrom befree-2016 NP294078.RAVa1Bt8cTfrfFn7I3KTfqL-XZGr7pGiNZNAcN_VX92fg130_provenance.
- NP294078.RAVa1Bt8cTfrfFn7I3KTfqL-XZGr7pGiNZNAcN_VX92fg130_assertion wasGeneratedBy ECO_0000203 NP294078.RAVa1Bt8cTfrfFn7I3KTfqL-XZGr7pGiNZNAcN_VX92fg130_provenance.